Neurorehabilitation is a complex medical procedure that targets on recovering from nervous system injury or damage and to minimize and/or compensate for any functional, non-functional alteration resulting from the injury. In 2014, the World health organization (WHO) reported that neurological disorder affects 15 million people globally every year, out of which, 5 million people suffer from permanent disability. Moreover, multiple sclerosis affects 2.5 million people and 10 million individuals are affected with Parkinson’s disease per year across the world. Rising cases of neural disease in people increases the demand of neurorahab centers as well as neurorehabilitation devices to provide simplified life and physical independence to patients.
Increasing number of neurological disease and growing awareness regarding health as well as growing investment in healthcare industry are expected to drive growth of the global neurorehabilitation devices market. For instance, in 2015, Centers for Disease Control and Prevention (CDCP) estimated around 130,000 people suffer fatal stroke in U.S. per year.
Moreover, rise in the number of patients with Parkinson’s disease requiring extensive use neurorehabilitation devices in the regions such as U.K., U.S., Iceland, Ireland, and Finland are also expected to boost growth of the global neurorehabilitaion devices market.
High cost and difficulty associated to the usage of these devices particularly in low and middle-income regions such as Africa, Middle East and Latin America and lack of skilled professionals are expected to hamper growth of the neurorehabilitation devices market.
Brain computer Interface
Traumatic Brain Injury
The neurorehabilitation devices market is regionally divided into North America, Latin America, Asia Pacific, Europe, Africa, and Middle East.
Among regions, North America is expected to witness a strong growth in the global market of neurorehabilitation devices due to increasing use and advancement of new neurorehabilitation devices as North America has large number of patients with neurological disorders. In 2016, the world health organization (WHO) reported that North America and Europe together held around 34% of the share in the global market of neurorehabilitation devices.
Moreover, Asia Pacific is also expected witness robust growth in the neurorehabilitation devices market due to increasing awareness among people and investment in health care.
Major players active in the neurorehabilitation devices market include Ectron Ltd., Medtronic, Tyromotion, St Jude Medical Inc., Denecor, Helius, Kinetic Muscles, Neurostyle, Bioness, Inc., Hocoma AG, Agiliad, Bioxtreme Robotics Rehabilitation, Alter G Inc., Ekso Bionics Holding Inc., Interactive Motion Technologies, Kinestica, and Medtronic Plc.
Key players are adopting various strategies such as collaborations, and mergers to strengthen their product portfolio. For instance, in September 2016, Hocoma announced the merger with DIH International that creates rehabilitation solutions and medication management.
Moreover, in 2017, Ectron Ltd. & Tyromotion collaborated and introduced Tyromotion’s PABLO, a modern therapy and assessment device for treating neurological disorders.
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Neurorehabilitation Devices Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Neurorehabilitation Devices Industry Impact
Chapter 2 Global Neurorehabilitation Devices Competition by Types, Applications, and Top Regions and Countries
2.1 Global Neurorehabilitation Devices (Volume and Value) by Type
2.3 Global Neurorehabilitation Devices (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Neurorehabilitation Devices Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Neurorehabilitation Devices Market Analysis
Chapter 6 East Asia Neurorehabilitation Devices Market Analysis
Chapter 7 Europe Neurorehabilitation Devices Market Analysis
Chapter 8 South Asia Neurorehabilitation Devices Market Analysis
Chapter 9 Southeast Asia Neurorehabilitation Devices Market Analysis
Chapter 10 Middle East Neurorehabilitation Devices Market Analysis
Chapter 11 Africa Neurorehabilitation Devices Market Analysis
Chapter 12 Oceania Neurorehabilitation Devices Market Analysis
Chapter 13 South America Neurorehabilitation Devices Market Analysis
Chapter 14 Company Profiles and Key Figures in Neurorehabilitation Devices Business
Chapter 15 Global Neurorehabilitation Devices Market Forecast (2021-2027)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027